Full-length MAVS, a mitochondrial antiviral-signaling protein, inhibits hepatitis E virus replication, requiring JAK-STAT signaling

被引：0
|
作者：
Qu, Changbo [1 ,2 ,3 ]
Li, Yang [4 ]
Li, Yunlong [4 ]
Pan, Yihang [1 ]
机构：
[1] Sun Yat Sen Univ, Precis Med Res Ctr, Tomas Lindahl Nobel Laureate Lab, Affiliated Hosp 7, Shenzhen 518107, Peoples R China
[2] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands
[4] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3015 CN Rotterdam, Netherlands
来源：
ARCHIVES OF VIROLOGY | 2022年 / 167卷 / 05期
关键词：
RIG-I; C-VIRUS;
D O I：
10.1007/s00705-022-05415-9
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Hepatitis E virus (HEV) infection is the leading cause of acute hepatitis worldwide. The mitochondrial antiviral signaling protein (MAVS)-mediated interferon (IFN) response plays a pivotal role in hepatic antiviral immunity. However, little is known about the effect of overexpression of MAVS on HEV infection. Full-length MAVS (FL-MAVS) is the main form of MAVS that increases the production of IFNs. Here, we studied the effect of FL-MAVS on HEV infection. We found that overexpression of FL-MAVS profoundly inhibited HEV replication. Furthermore, we showed that the anti-HEV effect of FL-MAVS is largely dependent on JAK-STAT signaling activation.
引用
收藏
页码：1293 / 1300
页数：8
相关论文
共 50 条
  • [21] Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-γ stimuli
    Hosui, A
    Ohkawa, K
    Ishida, H
    Sato, A
    Nakanishi, F
    Ueda, K
    Takehara, T
    Kasahara, A
    Sasaki, Y
    Hori, M
    Hayashi, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) : 28562 - 28571
  • [22] Respiratory Syncytial Virus Nonstructural Protein NS1 Colocalizes with Mitochondrial Antiviral Signaling (MAVS) Protein Following Infection
    Boyapalle, S.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB23 - AB23
  • [23] TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway
    Zhu, X.
    Xie, C.
    Li, Y-m
    Huang, Z-l
    Zhao, Q-y
    Hu, Z-x
    Wang, P-p
    Gu, Y-r
    Gao, Z-l
    Peng, L.
    [J]. CELL DEATH & DISEASE, 2016, 7 : e2239 - e2239
  • [24] The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
    Wei, Congwen
    Ni, Caifei
    Song, Ting
    Liu, Yu
    Yang, XiaoLi
    Zheng, Zirui
    Jia, Yongxia
    Yuan, Yuan
    Guan, Kai
    Xu, Yang
    Cheng, Xiaozhong
    Zhang, Yanhong
    Yang, Xiao
    Wang, Youliang
    Wen, Chaoyang
    Wu, Qing
    Shi, Wei
    Zhong, Hui
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (02): : 1158 - 1168
  • [25] TRIM22 inhibits respiratory syncytial virus replication by targeting JAK-STAT1/2 signaling
    Wang, Yishu
    Chen, Yiling
    Lin, Ying
    Quan, Yingqin
    Xiao, Xiaoping
    Zhang, Renli
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3412 - 3419
  • [26] Protein tyrosine phosphatase εC selectively inhibits interleukin-6-and interleukin-10-induced JAK-STAT signaling
    Tanuma, N
    Shima, H
    Nakamura, K
    Kikuchi, K
    [J]. BLOOD, 2001, 98 (10) : 3030 - 3034
  • [27] Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling
    Kitagawa, Yoshinori
    Yamaguchi, Mayu
    Kohno, Miki
    Sakai, Madoka
    Itoh, Masae
    Gotoh, Bin
    [J]. FEBS LETTERS, 2020, 594 (05) : 864 - 877
  • [28] Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-κB and JAK-STAT signaling pathway
    Ding, Yi
    Chen, Lizhu
    Wu, Wenjiao
    Yang, Jie
    Yang, Zifeng
    Liu, Shuwen
    [J]. MICROBES AND INFECTION, 2017, 19 (12) : 605 - 615
  • [29] Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-κB and JAK-STAT Signaling Pathways
    Feng, Mingkai
    Zhang, Qiao
    Wu, Wenjiao
    Chen, Lizhu
    Gu, Shuyin
    Ye, Yilu
    Zhong, Yingyuan
    Huang, Qi
    Liu, Shuwen
    [J]. JOURNAL OF VIROLOGY, 2021, 95 (06)
  • [30] Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1
    Yunlong Li
    Zhijiang Miao
    Pengfei Li
    Ruyi Zhang
    Denis E. Kainov
    Zhongren Ma
    Robert A. de Man
    Maikel P. Peppelenbosch
    Qiuwei Pan
    [J]. Archives of Virology, 2021, 166 : 2005 - 2010
12345